Stonepine Capital Management, LLC Acadia Pharmaceuticals Inc Transaction History
Stonepine Capital Management, LLC
- $124 Billion
- Q4 2024
A detailed history of Stonepine Capital Management, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 220,000 shares of ACAD stock, worth $3.98 Million. This represents 3.26% of its overall portfolio holdings.
Number of Shares
220,000
Previous 196,895
11.73%
Holding current value
$3.98 Million
Previous $3.03 Billion
33.31%
% of portfolio
3.26%
Previous 1.91%
Shares
5 transactions
Others Institutions Holding ACAD
# of Institutions
316Shares Held
164MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$775 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$252 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$218 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$157 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$132 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.93B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...